GlaxoSmithKline Consumer Healthcare has expanded its ‘Horlicks’ portfolio with the launch of a new flavour ‘Horlicks Kesar Badaam’. This is the fourth variant in the Horlicks portfolio while the other flavours available are Malt, Chocolate and Elaichi.
The new variant, which has been launched in two packs; 400g refill for Rs 220 and 400g jar for Rs 225, will be sold through traditional and modern retail outlets across the country.
GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK, a global science based healthcare company. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.
